Mara Walsh, OD in Aurora, CO - Medicare Optometrist Provider

Mara Walsh, OD is a medicare enrolled "Optometrist" provider in Aurora, Colorado. Her current practice location is 13955 East Mississippi, Aurora, Colorado. You can reach out to her office (for appointments etc.) via phone at (303) 695-4999.

Mara Walsh is licensed to practice in Colorado (license number 2307) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1598861957.

Contact Information

	Mara Walsh, OD
	13955 East Mississippi, Aurora, CO 80012
	(303) 695-4999
	(303) 695-0896

Healthcare Provider's Profile

Full Name	Mara Walsh
Gender	Female
Speciality	Optometrist
Location	13955 East Mississippi, Aurora, Colorado
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1598861957
Provider Enumeration Date: 09/15/2006
Last Update Date: 07/08/2007

Medicare PECOS Information:

PECOS PAC ID: 4183644248
Enrollment ID: I20051205000066

Medical Identifiers

Medical identifiers for Mara Walsh such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1598861957	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	2307 (Colorado)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Mara Walsh allows following entities to bill medicare on her behalf.

Provider Name	Sowash Optometry Group Pc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1336172055 PECOS PAC ID: 9830195858 Enrollment ID: O20061016000359

News Archive

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Millennium: The Takeda Oncology Company today reported results from a randomized, international Phase III clinical trial comparing subcutaneous and intravenous administration of VELCADE (bortezomib) in patients with relapsed multiple myeloma. These data were presented at the 52nd annual meeting of the American Society of Hematology, held December 4-7 in Orlando, Florida.

Imaging Healthcare Specialists implements successful radiation dose reduction program

According to an article in the November issue of the Journal of the American College of Radiology, a medical imaging facility in San Diego, Imaging Healthcare Specialists, has implemented a successful radiation dose reduction program, reducing radiation exposure by up to 90 percent in some patients.

Kyowa Hakko Kirin enters into distribution agreement with Hisamitsu Pharmaceutical

Orexo AB announces today that its partner Kyowa Hakko Kirin Co., Ltd. has entered a joint distribution agreement for the cancer pain drug KW-2246 (Orexo's sublingual fentanyl product) with the pharmaceutical company Hisamitsu Pharmaceutical Co., Inc.

Researchers discover how c-Cbl protein modulates tumor growth

Immune checkpoints are surface proteins that cancer cells use to evade immune response. These surface proteins are critical for cancer cell growth and drugs targeting these proteins have revolutionized the management of patients with a wide array of cancers.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mara Walsh is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mara Walsh, OD 11103 West Avenue, San Antonio, TX 78213 Ph: (210) 524-6803	Mara Walsh, OD 13955 East Mississippi, Aurora, CO 80012 Ph: (303) 695-4999

News Archive

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Imaging Healthcare Specialists implements successful radiation dose reduction program

Kyowa Hakko Kirin enters into distribution agreement with Hisamitsu Pharmaceutical

Researchers discover how c-Cbl protein modulates tumor growth

Optometrist in Aurora, CO

Brian Richard Williams, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 13955 E Mississippi Ave, Aurora, CO 80012 Phone: 303-695-4999
Dr. John Peter Blink Ii, OD Optometrist Medicare: Medicare Enrolled Practice Location: 13955 E Mississippi Ave, Aurora, CO 80012 Phone: 303-696-4999
Adventure Dental Vision And Orthodontics Optometrist Medicare: Not Enrolled in Medicare Practice Location: 9333 E Colfax Ave, Aurora, CO 80010 Phone: 720-697-5332 Fax: 720-257-5337
Elizabeth Helen Kaye, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 23473 E Moraine Pl, Aurora, CO 80016 Phone: 720-810-3926
Developmental Pathways, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 14280 E Jewell Ave Ste A, Aurora, CO 80012 Phone: 303-360-6600 Fax: 303-341-0382
Thompson Sowash, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 13955 E Mississippi, Aurora, CO 80012 Phone: 303-695-4999 Fax: 303-695-0896
National Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 24101 E Orchard Rd Unit D, Aurora, CO 80016 Phone: 303-600-9087

Mara Walsh, OD - Medicare Optometrist in Aurora, CO

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Imaging Healthcare Specialists implements successful radiation dose reduction program

Kyowa Hakko Kirin enters into distribution agreement with Hisamitsu Pharmaceutical

Researchers discover how c-Cbl protein modulates tumor growth

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Study comparing subcutaneous, intravenous administration of VELCADE in relapsed MM patients presented at ASH

Imaging Healthcare Specialists implements successful radiation dose reduction program

Kyowa Hakko Kirin enters into distribution agreement with Hisamitsu Pharmaceutical

Researchers discover how c-Cbl protein modulates tumor growth

Optometrist in Aurora, CO